Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya
Clinical trial NCT05918406 · COMPLETED
Trial details
- NCT number
- NCT05918406
- Sponsor
- Oyster Point Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2023-08-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.